A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo

Clinical trial NCT01803035 · COMPLETED

Trial details

NCT number: NCT01803035
Sponsor: Lytix Biopharma AS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-bullous Impetigo

Start date: 2013-02-01
Primary completion: 2014-03-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.